BSE   18 Jun 13 | 12:00 AM 959.30 -7.1 (-0.73%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 532488 Face Value: 2

NSE   18 Jun 13 | 12:00 AM 961.75 -5.6 (-0.58%) Mkt Price (Rs)   Chg Rs (Chg %) Code: DIVISLAB

Performance 1 Week : Rs 968.80 (-0.98%) 1 Month : Rs 1,121.15 (-14.44%) 1 Year : Rs 945.25 (1.49%)

Smart Charts | Add to my portfolio | Derivative

News 22 May 13 08:41 Stock Recommendation: Divi's Labs, Zydus Wellness 05 Nov 12 13:38 Divi's Labs Q2 net increases 11% 06 Aug 12 15:54 Divi's Labs posts 63% jump in Q1 net at Rs 167.38 cr 14 May 12 09:21 Divi's Lab rises on healthy Q4 nos, dividend bounty 28 Jan 12 16:56 Divis Labs Q3 net up 21% at Rs 123 cr 21 Dec 11 00:16 Divi's gains on strong core business

Stock Summary

Shareholding Pattern Promoters 52.15 % Mutual Funds / UTI 13.26 % FI/Bank 0.05 % Insurance 0.00 % Others 0.00 % Govt 0.00 % FII 14.01 % Non-Institutions 20.53 % Depository Receipts 0.00 % Total 100.00 %

Key Financials (Rs cr) Mar 2013 Mar 2012 YOY Operating Income 657.50 721.51 -8.87 Total Expenses 407.31 431.49 -5.60 Operating Profit 250.19 290.02 -13.73 Other Income 7.60 1.02 645.10 PBDIT 257.79 291.04 -11.42 PBT 236.89 271.98 -12.90 Adjusted Net Profit 180.57 216.91 -16.75

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Glenmark Pharma. 575.10 1.07 15,577 Ranbaxy Labs. 352.40 -3.56 14,907 Wockhardt 1,112.75 2.58 12,194 Piramal Enterp. 560.30 5.64 9,669 Ipca Labs. 684.55 1.95 8,639

Funds Owning this Stock Scheme Name Value (Rs cr) Reliance Equity Opportunities Fund - Direct (G) 310.53 Reliance Equity Opportunities Fund - Inst (G) 286.56 Reliance Equity Opportunities Fund (G) 286.56 Reliance Growth Fund - (G) 245.49 Reliance Growth Fund - Inst (G) 223.99

Announcements

Research Reports Date Broker Action Price (Rs) Report 12/11 Motilal Oswal Buy 1148 24/09 Nirmal Bang Buy 1107 07/08 Karvy Stock Broking Buy 1116 07/08 Motilal Oswal Buy 1125 01/02 Motilal Oswal Buy 783